Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis
- Author
- VAN DEN ELSKAMP, I. J1 ; BODEN, B1 ; POLMAN, C. H10 ; UITDEHAAG, B. M. J3 ; BARKHOF, F7 ; DATTOLA, V2 ; KNOL, D. L3 ; FILIPPI, M4 ; KAPPOS, L5 ; FAZEKAS, F6 ; WAGNER, K7 ; POHL, C8 ; SANDBRINK, R9
[1] Department of Radiology, MS Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands
[2] Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy
[3] Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands
[4] Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy
[5] Department of Neurology, University Hospital, University of Basel, Basel, Switzerland
[6] Department of Neurology, Medical University of Graz, Graz, Austria
[7] Bayer-Schering Pharma, Berlin, Germany
[8] Department of Neurology, University Hospital Bonn, Bonn, Germany
[9] Department of Neurology, Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany
[10] Department of Neurology, MS Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands - Source
Neuroradiology (Berlin. Print). 2010, Vol 52, Num 10, pp 875-881, 7 p ; ref : 21 ref
- CODEN
- NRDYAB
- ISSN
- 0028-3940
- Scientific domain
- Neurology; Radiology, nuclear medicine
- Publisher
- Springer, Heidelberg
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Cerebral atrophy Multiple sclerosis SIENA Sample size
- Keyword (fr)
- Cortex cérébral Court terme Essai clinique Pathologie du système nerveux Pronostic Radiodiagnostic Sclérose en plaques Taille échantillon Encéphale Maladie inflammatoire Pathologie du système nerveux central Système nerveux central
- Keyword (en)
- Cerebral cortex Short term Clinical trial Nervous system diseases Prognosis Radiodiagnosis Multiple sclerosis Sample size Encephalon Inflammatory disease Central nervous system disease Central nervous system
- Keyword (es)
- Corteza cerebral Corto plazo Ensayo clínico Sistema nervioso patología Pronóstico Radiodiagnóstico Esclerosis en placa Tamaño muestra Encéfalo Enfermedad inflamatoria Sistema nervosio central patología Sistema nervioso central
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07D Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B24 Investigative techniques, diagnostic techniques (general aspects) / 002B24A Radiodiagnosis. Nmr imagery. Nmr spectrometry / 002B24A06 Nervous system
- Francis
- 770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G04 Miscellaneous
- Discipline
- Neurology Psychopathology. Psychiatry. Clinical psychology Scanning and diagnostic techniques
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 23302028
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00234-009-0645-1 
https://dx.doi.org/10.1007/s00234-009-0645-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Neuroradiology (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Neuroradiology (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"881\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"VAN DEN ELSKAMP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"I. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"BODEN, B\";i:1;s:12:\"POLMAN, C. H\";i:2;s:18:\"UITDEHAAG, B. M. J\";i:3;s:10:\"BARKHOF, F\";i:4;s:10:\"DATTOLA, V\";i:5;s:10:\"KNOL, D. L\";i:6;s:10:\"FILIPPI, M\";i:7;s:9:\"KAPPOS, L\";i:8;s:10:\"FAZEKAS, F\";i:9;s:9:\"WAGNER, K\";i:10;s:7:\"POHL, C\";i:11;s:12:\"SANDBRINK, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NRDYAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Neuroradiology (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Neuroradiology (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"881\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"VAN DEN ELSKAMP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"I. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"BODEN, B\";i:1;s:12:\"POLMAN, C. H\";i:2;s:18:\"UITDEHAAG, B. M. J\";i:3;s:10:\"BARKHOF, F\";i:4;s:10:\"DATTOLA, V\";i:5;s:10:\"KNOL, D. L\";i:6;s:10:\"FILIPPI, M\";i:7;s:9:\"KAPPOS, L\";i:8;s:10:\"FAZEKAS, F\";i:9;s:9:\"WAGNER, K\";i:10;s:7:\"POHL, C\";i:11;s:12:\"SANDBRINK, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NRDYAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Neuroradiology (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Neuroradiology (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"881\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"VAN DEN ELSKAMP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"I. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"BODEN, B\";i:1;s:12:\"POLMAN, C. H\";i:2;s:18:\"UITDEHAAG, B. M. J\";i:3;s:10:\"BARKHOF, F\";i:4;s:10:\"DATTOLA, V\";i:5;s:10:\"KNOL, D. L\";i:6;s:10:\"FILIPPI, M\";i:7;s:9:\"KAPPOS, L\";i:8;s:10:\"FAZEKAS, F\";i:9;s:9:\"WAGNER, K\";i:10;s:7:\"POHL, C\";i:11;s:12:\"SANDBRINK, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NRDYAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Neuroradiology (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Neuroradiology (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"881\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"VAN DEN ELSKAMP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"I. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"BODEN, B\";i:1;s:12:\"POLMAN, C. H\";i:2;s:18:\"UITDEHAAG, B. M. J\";i:3;s:10:\"BARKHOF, F\";i:4;s:10:\"DATTOLA, V\";i:5;s:10:\"KNOL, D. L\";i:6;s:10:\"FILIPPI, M\";i:7;s:9:\"KAPPOS, L\";i:8;s:10:\"FAZEKAS, F\";i:9;s:9:\"WAGNER, K\";i:10;s:7:\"POHL, C\";i:11;s:12:\"SANDBRINK, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NRDYAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00234-009-0645-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Neuroradiology (Berlin. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Neuroradiology (Berl., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"52\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"875\";s:8:\"\u0000*\u0000epage\";s:3:\"881\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:15:\"VAN DEN ELSKAMP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"I. J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"BODEN, B\";i:1;s:12:\"POLMAN, C. H\";i:2;s:18:\"UITDEHAAG, B. M. J\";i:3;s:10:\"BARKHOF, F\";i:4;s:10:\"DATTOLA, V\";i:5;s:10:\"KNOL, D. L\";i:6;s:10:\"FILIPPI, M\";i:7;s:9:\"KAPPOS, L\";i:8;s:10:\"FAZEKAS, F\";i:9;s:9:\"WAGNER, K\";i:10;s:7:\"POHL, C\";i:11;s:12:\"SANDBRINK, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NRDYAB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:95:\"Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Heidelberg\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
